Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
J Immunol ; 167(6): 3521-9, 2001 Sep 15.
Article in English | MEDLINE | ID: mdl-11544346

ABSTRACT

Polymyositis and dermatomyositis are diseases characterized by muscle weakness and muscle inflammatory infiltrates. Their pathogenesis remains unclear. A central role for endomysial autoaggressive CD8(+) T cells is suspected in polymyositis and for perivascular B cells in dermatomyositis. We compared the T cell repertoire of 10 polymyositis and 10 dermatomyositis patients by immunoscope, a method providing a global assessment of the T cell repertoire and a sensitive detection of clonal T cell expansions. Samples were analyzed qualitatively and quantitatively in the blood (unsorted cells and CD4(+) and CD8(+) cells) and in muscle infiltrates. Dramatic perturbations of the T cell repertoire were observed in the blood of polymyositis but not dermatomyositis patients (p < 0.0005), the latter being undistinguishable from controls. These perturbations were due to oligoclonal expansions of CD8(+) T cells and most blood clonal expansions were also found in muscle. These results indicate that the pathogenesis of polymyositis and dermatomyositis is different and reinforce the view that polymyositis but not dermatomyositis is an autoimmune CD8(+) T cell-mediated disease. Moreover, this method may be helpful for the differential diagnosis of polymyositis and dermatomyositis and for noninvasive follow-up of polymyositis patients.


Subject(s)
Autoimmune Diseases/immunology , Complementarity Determining Regions/analysis , Dermatomyositis/immunology , Lymphocyte Count , Polymyositis/immunology , Receptors, Antigen, T-Cell, alpha-beta/chemistry , T-Lymphocyte Subsets , Adult , Aged , Aged, 80 and over , Autoimmune Diseases/blood , Autoimmune Diseases/diagnosis , Autoimmune Diseases/etiology , CD8-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/pathology , Cell Separation , Clone Cells/pathology , Dermatomyositis/blood , Dermatomyositis/diagnosis , Dermatomyositis/etiology , Diagnosis, Differential , Female , Flow Cytometry , Humans , Male , Middle Aged , Muscle, Skeletal/immunology , Muscle, Skeletal/pathology , Polymyositis/blood , Polymyositis/diagnosis , Polymyositis/etiology , Recurrence
2.
J Virol ; 73(7): 5698-706, 1999 Jul.
Article in English | MEDLINE | ID: mdl-10364320

ABSTRACT

Lentiviruses have in their transmembrane glycoprotein (TM) a highly immunogenic structure referred to as the principal immunodominant domain (PID). The PID forms a loop of 5 to 7 amino acids between two conserved cysteines. Previous studies showed that envelope (Env) glycoprotein functions of feline immunodeficiency virus (FIV) could be retained after extensive mutation of the PID loop sequence, in spite of its high conservation. In order to compare Env function in different lentiviruses, either random mutations were introduced in the PID loop sequence of human immunodeficiency virus type 1 (HIV-1) or the entire HIV-1 PID loop was replaced by the corresponding PID loop of FIV or simian immunodeficiency virus (SIV). In the macrophage-tropic HIV-1 ADA Env, mutations impaired the processing of the gp160 Env precursor, thereby abolishing viral infectivity. However, 6 of the 108 random Env mutants that were screened retained the capacity to induce cell membrane fusion. The SIV and FIV sequences and five random mutations were then introduced in the context of T-cell-line-adapted HIV-1 LAI which, although phenotypically distant from HIV-1 ADA, has an identical PID loop sequence. In contrast to the situation for HIV-1 ADA mutants, the cleavage of the Env precursor was unaffected in most HIV-1 LAI mutants. Such mutations, however, resulted in increased shedding of the gp120 surface glycoprotein (SU) from the gp41 TM. The HIV-1 LAI Env mutants showed high fusogenic efficiency. Three Env mutants retained the capacity to mediate virus entry in target cells, although less efficiently than the wild-type Env, and allowed the reconstitution of infectious molecular clones. These results indicated that in HIV-1, like FIV, the conserved PID sequence can be changed without impairing Env function. However, functional constraints on the PID of HIV-1 vary depending on the structural context of Env, presumably in relation to the role of the PID in the interaction of the SU and TM subunits and the stability of the Env complex.


Subject(s)
HIV Envelope Protein gp120/metabolism , HIV Envelope Protein gp160/metabolism , HIV Envelope Protein gp41/metabolism , HIV-1/metabolism , Immunodominant Epitopes/metabolism , Animals , COS Cells , Cats , Cell Line, Transformed , HIV Envelope Protein gp120/genetics , HIV Envelope Protein gp120/immunology , HIV Envelope Protein gp160/genetics , HIV Envelope Protein gp160/immunology , HIV Envelope Protein gp41/genetics , HIV-1/genetics , HIV-1/immunology , HIV-1/physiology , HeLa Cells , Humans , Immunodominant Epitopes/genetics , Membrane Fusion , Mutagenesis , Protein Processing, Post-Translational
3.
J Virol ; 73(5): 3661-71, 1999 May.
Article in English | MEDLINE | ID: mdl-10196258

ABSTRACT

Strains of the feline immunodeficiency virus (FIV) presently under investigation exhibit distinct patterns of in vitro tropism. In particular, the adaptation of FIV for propagation in Crandell feline kidney (CrFK) cells results in the selection of strains capable of forming syncytia with cell lines of diverse species origin. The infection of CrFK cells by CrFK-adapted strains appears to require the chemokine receptor CXCR4 and is inhibited by its natural ligand, stromal cell-derived factor 1alpha (SDF-1alpha). Here we found that inhibitors of CXCR4-mediated infection by human immunodeficiency virus type I (HIV-1), such as the bicyclam AMD3100 and short peptides derived from the amino-terminal region of SDF-1alpha, also blocked infection of CrFK by FIV. Nevertheless, we observed differences in the ranking order of the peptides as inhibitors of FIV and HIV-1 and showed that such differences are related to the species origin of CXCR4 and not that of the viral envelope. These results suggest that, although the envelope glycoproteins of FIV and HIV-1 are substantially divergent, FIV and HIV-1 interact with CXCR4 in a highly similar manner. We have also addressed the role of CXCR4 in the life cycle of primary isolates of FIV. Various CXCR4 ligands inhibited infection of feline peripheral blood mononuclear cells (PBMC) by primary FIV isolates in a concentration-dependent manner. These ligands also blocked the viral transduction of feline PBMC by pseudotyped viral particles when infection was mediated by the envelope glycoprotein of a primary FIV isolate but not by the G protein of vesicular stomatitis virus, indicating that they act at an envelope-mediated step and presumably at viral entry. These findings strongly suggest that primary and CrFK-adapted strains of FIV, despite disparate in vitro tropisms, share usage of CXCR4.


Subject(s)
Immunodeficiency Virus, Feline/metabolism , Receptors, CXCR4/metabolism , Adaptation, Biological , Animals , Anti-HIV Agents/pharmacology , Cats , Cell Line, Transformed , Chemokine CXCL12 , Chemokines, CXC/pharmacology , Concanavalin A/pharmacology , HeLa Cells , Humans , Immunodeficiency Virus, Feline/drug effects , Immunodeficiency Virus, Feline/isolation & purification , Immunodeficiency Virus, Feline/physiology , Ligands , Lymphocyte Activation , Lymphocytes/virology , Mice , Mitogens/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...